Correlation Between Athira Pharma and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both Athira Pharma and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Athira Pharma and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Athira Pharma and Fortress Biotech, you can compare the effects of market volatilities on Athira Pharma and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Athira Pharma with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Athira Pharma and Fortress Biotech.

Diversification Opportunities for Athira Pharma and Fortress Biotech

0.3

Correlation Coefficient

Athira Pharma  Fortress Biotech

Weak diversification

The 3 months correlation between Athira and Fortress is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Athira Pharma and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Athira Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Athira Pharma are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Athira Pharma i.e., Athira Pharma and Fortress Biotech go up and down completely randomly.

Pair Corralation between Athira Pharma and Fortress Biotech

Given the investment horizon of 90 days Athira Pharma is expected to generate 0.97 times more return on investment than Fortress Biotech. However, Athira Pharma is 1.03 times less risky than Fortress Biotech. It trades about -0.01 of its potential returns per unit of risk. Fortress Biotech is currently generating about -0.02 per unit of risk. If you would invest  338.00  in Athira Pharma on September 23, 2024 and sell it today you would lose (280.00) from holding Athira Pharma or give up 82.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Athira Pharma  vs.  Fortress Biotech

Athira Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Athira Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Athira Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Fortress Biotech

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Athira Pharma and Fortress Biotech

The main advantage of trading using opposite Athira Pharma and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Athira Pharma position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind Athira Pharma and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.